PDF
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
620kB |
Item Type: | Review |
---|---|
Title: | Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases |
Creators Name: | Mähler, A., Mandel, S., Lorenz, M., Ruegg, U., Wanker, E.E., Boschmann, M. and Paul, F. |
Abstract: | Neurodegenerative disorders show an increasing prevalence in a number of highly developed countries. Often, these diseases require life-long treatment mostly with drugs which are costly and mostly accompanied by more or less serious side-effects. Their heterogeneous manifestation, severity and outcome pose the need for individualised treatment options. There is an intensive search for new strategies not only for treating but also for preventing these diseases. Green tea and green tea extracts seem to be such a promising and safe alternative. However, data regarding the beneficial effects and possible underlying mechanism, specifically in clinical trials, are rare and rather controversial or non-conclusive. This review outlines the existing evidence from preclinical studies (cell and tissue cultures and animal models) and clinical trials regarding preventive and therapeutic effects of epigallcatechin-3-gallate in neurodegenerative diseases and considers antioxidative vs. pro-oxidative properties of the tea catechin important for dosage recommendations. |
Keywords: | Neurological Diseases, Predictive and Personalised Medicine, Targeted Prevention, Green Tea, Epigallocatechin-3-Gallate, Tailored Therapy |
Source: | EPMA Journal |
ISSN: | 1878-5077 |
Publisher: | BioMed Central |
Volume: | 4 |
Number: | 1 |
Page Range: | 5 |
Date: | 18 February 2013 |
Official Publication: | https://doi.org/10.1186/1878-5085-4-5 |
PubMed: | View item in PubMed |
Repository Staff Only: item control page